catalysthcc.com
New FDA Leadership Changes Priorities But Doesn’t Change Administration Regulations, Panel Discussion Says
Biotech Investing News— Biotech Investing News reporters this week covered a panel featuring Catalyst’s President, Nancy Bradish Myers. In the panel, which took place on the first day of the JP Morgan Healthcare conference, at the coinciding Biotech Showcase, Myers discussed how new leaders at FDA are shaping the agency. She underscored that now is the time “for